Literature DB >> 24570943

High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?

Claudio Zavaglia1, Andrea Mancuso1, Antonella Foschi1, Antonio Rampoldi2.   

Abstract

Entities:  

Year:  2013        PMID： 24570943      PMCID： PMC3924684          DOI： 10.3978/j.issn.2304-3881.2013.05.02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  20 in total

1.  High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations.

Authors:  Franco Orsi; Lian Zhang; Paolo Arnone; Gianluigi Orgera; Guido Bonomo; Paolo Della Vigna; Lorenzo Monfardini; Kun Zhou; Wenzhi Chen; Zhibiao Wang; Umberto Veronesi
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

2.  Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.

Authors:  Young-sun Kim; Hyo Keun Lim; Hyunchul Rhim; Min Woo Lee; Dongil Choi; Won Jae Lee; Seung Woon Paik; Kwang Cheol Koh; Joon Hyeok Lee; Moon Seok Choi; Geum-Youn Gwak; Byung Chul Yoo
Journal:  J Hepatol       Date:  2012-09-27       Impact factor: 25.083

Review 3.  Clinical and future applications of high intensity focused ultrasound in cancer.

Authors:  Osama Al-Bataineh; Jürgen Jenne; Peter Huber
Journal:  Cancer Treat Rev       Date:  2011-09-15       Impact factor: 12.111

4.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

5.  Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.

Authors:  Feng Wu; Zhi-Biao Wang; Wen-Zhi Chen; Jian-Zhong Zou; Jin Bai; Hui Zhu; Ke-Quan Li; Cheng-Bing Jin; Fang-Lin Xie; Hai-Bing Su
Journal:  Radiology       Date:  2005-05       Impact factor: 11.105

6.  Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.

Authors:  Tan To Cheung; Sheung Tat Fan; Ferdinand S K Chu; Caroline R Jenkins; Kenneth S H Chok; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; See Ching Chan; Thomas C C Yau; Ronnie T P Poon; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-04       Impact factor: 3.647

7.  Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.

Authors:  Yu-Yuan Li; Wei-Hong Sha; Yong-Jian Zhou; Yu-Qiang Nie
Journal:  J Gastroenterol Hepatol       Date:  2007-12       Impact factor: 4.029

8.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

9.  Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma.

Authors:  Feng Wu; Zhi-Biao Wang; Wen-Zhi Chen; Hui Zhu; Jin Bai; Jian-Zhong Zou; Ke-Quan Li; Cheng-Bing Jin; Fang-Lin Xie; Hai-Bing Su
Journal:  Ann Surg Oncol       Date:  2004-11-15       Impact factor: 5.344

Review 10.  Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours.

Authors:  J W Wijlemans; L W Bartels; R Deckers; M Ries; W P Th M Mali; C T W Moonen; M A A J van den Bosch
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909
View more
  7 in total

Review 1.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

2.  Enhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.

Authors:  Nick Frazier; Allison Payne; Christopher Dillon; Nithya Subrahmanyam; Hamidreza Ghandehari
Journal:  Nanomedicine       Date:  2016-11-29       Impact factor: 5.307

Review 3.  Emerging Therapeutic Strategies for Brain Tumors.

Authors:  Muna Aryal; Tyrone Porter
Journal:  Neuromolecular Med       Date:  2021-08-18       Impact factor: 3.843

Review 4.  Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma.

Authors:  Kylie E Zane; Paul B Nagib; Sajid Jalil; Khalid Mumtaz; Mina S Makary
Journal:  World J Hepatol       Date:  2022-05-27

5.  Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors.

Authors:  Nan Zhang; Ronghui Wang; Junnian Hao; Yang Yang; Hongmi Zou; Zhigang Wang
Journal:  Int J Nanomedicine       Date:  2017-10-05

Review 6.  A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.

Authors:  Claire Faltermeier; Ronald W Busuttil; Ali Zarrinpar
Journal:  Diseases       Date:  2015-09-29

7.  Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma.

Authors:  Mrigendra B Karmacharya; Laith R Sultan; Stephen J Hunt; Chandra M Sehgal
Journal:  Sci Rep       Date:  2021-07-30       Impact factor: 4.996
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.